A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl- XL

By Hwang Jung  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1434-1442

Springer Publishing Company

Access to resources Recommend Favorite

Romidepsin: a novel histone deacetylase inhibitor for cancer

By Bertino Erin M   Otterson Gregory A  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1151-1158

Informa Healthcare

Access to resources Recommend Favorite

Comprehensive Analysis for Histone Acetylation of Human Colon Cancer Cells Treated with a novel HDAC Inhibitor

By  

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1866-1873

Bentham Science Publishers

Access to resources Recommend Favorite

Pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to Pax5 Promoter Region

By  

Current Cancer Drug Targets, Vol. 17, Iss. 2, 2017-01 ,pp. : 169-176

Bentham Science Publishers

Access to resources Recommend Favorite

Factors affecting the pharmacokinetic profile of MS-275, a novel histone deacetylase inhibitor, in patients with cancer

By Acharya Milin   Karp Judith   Sausville Edward   Hwang Kyunghwa   Ryan Qin   Gojo Ivana   Venitz Jűrgen   Figg William   Sparreboom Alex  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 367-375

Springer Publishing Company

Access to resources Recommend Favorite